Grameva Limited (BOM:539120)
India · Delayed Price · Currency is INR 95.60
-2.40 (-2.45%)
At close: Aug 4, 2026
Grameva Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 826.81 | 414.11 | 373.41 | 244.63 | 223.57 | |
Revenue Growth | 99.66% | 10.90% | 52.64% | 9.42% | 10.71% |
Cost of Revenue | 757.26 | 389.97 | 352.03 | 229.63 | 196.56 |
Gross Profit | 69.55 | 24.14 | 21.37 | 15 | 27.01 |
Selling, General & Admin | 6.34 | 4.25 | 2.84 | 2.31 | 2.2 |
Other Operating Expenses | 17.19 | 10.9 | 6.04 | 8.88 | 17.37 |
Operating Expenses | 27.76 | 18.54 | 11.62 | 12.95 | 21.46 |
Operating Income | 41.79 | 5.6 | 9.76 | 2.05 | 5.55 |
Interest Expense | -7.04 | -6.11 | -4.96 | -3.15 | -2.81 |
Interest & Investment Income | 9.31 | 6.29 | 0.44 | 2.46 | 0.37 |
Currency Exchange Gain (Loss) | -2.29 | 1.06 | - | 0.85 | 0.35 |
Other Non Operating Income (Expenses) | -0.51 | -1.29 | -0.45 | -0.13 | -0.41 |
EBT Excluding Unusual Items | 41.25 | 5.54 | 4.79 | 2.08 | 3.05 |
Gain (Loss) on Sale of Investments | 0 | - | - | - | - |
Asset Writedown | -0.05 | - | - | - | - |
Other Unusual Items | - | - | - | - | 0.41 |
Pretax Income | 41.21 | 5.54 | 4.79 | 2.08 | 3.47 |
Income Tax Expense | 11.03 | 0.67 | 1.34 | 0.38 | 2.01 |
Net Income | 30.17 | 4.87 | 3.45 | 1.7 | 1.46 |
Net Income to Common | 30.17 | 4.87 | 3.45 | 1.7 | 1.46 |
Net Income Growth | 519.19% | 41.37% | 103.00% | 16.38% | -8.76% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 |
Shares Change | - | 0.01% | - | - | - |
EPS (Basic) | 6.29 | 1.02 | 0.72 | 0.35 | 0.30 |
EPS (Diluted) | 6.29 | 1.02 | 0.72 | 0.35 | 0.30 |
EPS Growth | 519.19% | 41.36% | 103.00% | 17.94% | -9.09% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -89.19 | 15.58 | 5 | -2.83 | 2.22 |
Free Cash Flow Per Share | -18.58 | 3.25 | 1.04 | -0.59 | 0.46 |
Dividend Per Share | - | - | 0.200 | - | - |
Dividend Growth | - | - | 25.00% | - | - |
Gross Margin | 8.41% | 5.83% | 5.72% | 6.13% | 12.08% |
Operating Margin | 5.05% | 1.35% | 2.61% | 0.84% | 2.48% |
Profit Margin | 3.65% | 1.18% | 0.92% | 0.69% | 0.65% |
Free Cash Flow Margin | -10.79% | 3.76% | 1.34% | -1.16% | 0.99% |
EBITDA | 45.64 | 8.99 | 12.49 | 3.81 | 7.45 |
EBITDA Margin | 5.52% | 2.17% | 3.34% | 1.56% | 3.33% |
D&A For EBITDA | 3.85 | 3.4 | 2.73 | 1.76 | 1.9 |
EBIT | 41.79 | 5.6 | 9.76 | 2.05 | 5.55 |
EBIT Margin | 5.05% | 1.35% | 2.61% | 0.84% | 2.48% |
Effective Tax Rate | 26.77% | 12.09% | 28.02% | 18.17% | 57.89% |
Revenue as Reported | 833.83 | 421.38 | 374.68 | 249.58 | 227.44 |